G. Di Maggio

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice.

G. Colucci, E. Maiello, V. Gebbia, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).

A. Rossi, G. Colucci, E. Maiello, 2020, Clinical colorectal cancer.

Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group

Giuseppe Cuccu, A. Mancuso, A. la Sala, 2021, Pain and Therapy.

The potential role of nintedanib in treating colorectal cancer

A. Rossi, E. Maiello, P. Parente, 2017, Expert opinion on pharmacotherapy.

Combined modality treatments in pancreatic cancer

G. Colucci, E. Maiello, P. Di Sebastiano, 2012, Expert opinion on therapeutic targets.